Cognizant Technology Solutions Stock Price, News & Analysis

Cognizant has been selected by Freshfields Bruckhaus Deringer to manage their IT operations under a multi-year agreement. The partnership will enhance Freshfields' IT infrastructure, enabling 24x7 managed services and improved client service. Cognizant will also develop a technology transformation roadmap for Freshfields, aiming to boost flexibility, investment, and innovation within their business. This collaboration highlights Cognizant's role as a leader in digital transformation for major companies, underscoring their scalability and expertise.

Cognizant (NASDAQ: CTSH) announced that its Shared Investigator Platform (SIP) has reached over 250,000 users in more than 100 countries. Launched in 2016, SIP streamlines clinical trials by standardizing documents and facilitating collaboration among biopharmaceutical organizations. Utilization has surged by over 65% in the last two years, with SIP currently in use by seven major global biopharmaceutical firms. The platform expedites drug discovery and has been recognized by organizations like the UK's NIHR for enhancing research efficiency.

Cognizant has been chosen by AXA UK & Ireland as a technology partner to modernize and manage part of its IT operations. This multi-year agreement focuses on creating a digitally-enabled IT environment to enhance customer experience and reduce costs. Cognizant will provide managed services, cloud migration, and integrated IT services to support the transformation. AXA UK & Ireland aims to improve flexibility and data-driven decision-making through this partnership, which highlights Cognizant's capabilities as a leader in the insurance sector.

Cognizant's latest survey, sponsored by Economist Impact, highlights challenges faced by 2,000 global business leaders. Key findings show that 90% cite competing strategic imperatives, while 60% are adopting advanced technologies like quantum computing. Despite this, nearly 50% report not deriving significant value from tech investments. Additionally, 46% acknowledge a talent gap, and 90% see ESG considerations as vital, yet only 35% are incorporating them into strategies. This research underscores the need for businesses to prioritize technology, workforce strategies, and ESG actions for resilience in a competitive landscape.

Cognizant (CTSH) reported Q2 2022 revenue of $4.9 billion, up 7.0% year-over-year. Operating margin increased to 15.5%. The company repurchased 4.2 million shares for $300 million and plans to return $1.8 billion to shareholders in 2022. Despite revenue growth, Q2 bookings declined by 3%, raising concerns. Full-year guidance indicates revenue growth of 6.3%-7.3%. The CEO emphasized focus on client commitments amid labor market challenges.

Cognizant (NASDAQ: CTSH) has entered a multi-year agreement with Organon (NYSE: OGN) to enhance the delivery of healthcare products and improve supply chain management. The partnership involves providing industrial technology support at Organon's manufacturing sites across the UK, Netherlands, Belgium, and Indonesia, utilizing SAP's S4/HANA suite. This collaboration aims to boost manufacturing efficiency, increase medicinal yields, and reduce cycle times, facilitating faster access to vital therapies for women's health.

Cognizant has announced a multi-year agreement with Zurich Beteiligungs-AG, enhancing digital services for Zurich Germany's clients in the General Insurance sector. The partnership aims to modernize and manage Zurich's application landscape, reduce ownership costs, and accelerate the launch of new digital products. With joint DevOps teams, the collaboration will focus on AI, data, and cloud capabilities. Cognizant's expertise in application modernization is expected to drive further digital transformation, building on their existing successful relationship.

Cognizant (Nasdaq: CTSH) will announce its second quarter 2022 earnings results on July 27, 2022, post-market close. Management will hold a conference call at 5:00 p.m. Eastern to discuss the quarter's performance. Domestic participants can dial 877-810-9510, while international callers can reach 201-493-6778. A live broadcast will be available on the Investor Relations website, with replays accessible until August 10, 2022. Investors can expect insights into operations and financial metrics affecting the company's outlook.